-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Lowers Price Target to $812

Benzinga·08/11/2025 15:07:17
Listen to the news
Truist Securities analyst Srikripa Devarakonda maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and lowers the price target from $940 to $812.